gliclazide and Pituitary Neoplasms

gliclazide has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, YB; Wang, D; Wong, HK; Zhang, ZJ	1

Other Studies

1 other study(ies) available for gliclazide and Pituitary Neoplasms

Article	Year
18beta-glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway. Journal of neuro-oncology, 2014, Volume: 116, Issue:2 Topics: Adenoma; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Glycyrrhetinic Acid; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Pituitary Neoplasms; Reactive Oxygen Species; Signal Transduction; Time Factors; Transplantation, Heterologous	2014

Article

Year

18beta-glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway.

Journal of neuro-oncology, 2014, Volume: 116, Issue:2

Topics: Adenoma; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Glycyrrhetinic Acid; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Pituitary Neoplasms; Reactive Oxygen Species; Signal Transduction; Time Factors; Transplantation, Heterologous

2014